328
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Effectiveness of a Health Talk Education Program on Human Papillomavirus (HPV) Knowledge, Attitudes, and Intentions to Vaccinate Children Among Mothers of Secondary School Boys in Thua Thien Hue Province, Vietnam

ORCID Icon, & ORCID Icon
Pages 1207-1214 | Published online: 18 Aug 2020

References

  • World Health Organization. Human papilloma virus vaccines: WHO position paper. Wkly Epidemiol Rec. 2017;92(19):241–268.28530369
  • American Cancer Society. Cancer facts and figures; 2008 Available from: http://www.cancer.org/downloads/STT/2008CAFFfinalsecured.pdf. Accessed 729, 2009.
  • Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005;14(2):467–475. doi:10.1158/1055-9965.EPI-04-055115734974
  • Ryan DP, Mayer RJ. Anal carcinoma: histology, staging, epidemiology, treatment. CurrOpinOncol. 2000;12:345–352.
  • Daling JR, Madeleine MM, Johnson LG, et al. Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer. 2005;116(4):606–616. doi:10.1002/ijc.2100915825185
  • Parkin DM, Bray F. The burden of HPV-related cancers. Vaccine. 2006;21(24):S11–25. doi:10.1016/j.vaccine.2006.05.111
  • Saraiya M, Unger ER, Thompson TD, et al. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst. 2015;107(6):djv086. doi:10.1093/jnci/djv08625925419
  • HPV and cancer. HPV-Associated Cancer Diagnosis by Age. Atlanta, GA: CDC; 2017.
  • Viens LJ, Henley SJ, Watson M, et al. Human papillomavirus-associated cancers— United States, 2008–2012. MMWR Morb Mortal Wkly Rep. 2016;65(26):661–666. doi:10.15585/mmwr.mm6526a127387669
  • Centers for Disease Control and Prevention (CDC). Recommendations on the use of quadrivalent human papillomavirus vaccine in males—advisory committee on immunizations practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011;60(50):1705–1708.22189893
  • Centers for Disease Control and Prevention (CDC). FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the advisory committee on immunizations practices (ACIP). MMWR Morb Mortal Wkly Rep. 2010;59(20):630–632.20508594
  • Bruni L, Barrionuevo-Rosas L, Albero G. ICO information centre on HPV and cancer (HPV information centre). Hum Papillomavirus Relat Dis Viet Nam. 2014;202:12–18.
  • NationalInstitute of Hygiene and Epidemiology. Evaluating HPV vaccine delivery strategies in Vietnam. Available from: https://www.path.org/publications/files/CPVietnam_eval_hpv_vacc_deliv.pdf. Accessed 74 2017.
  • Bruni L, Barrionuevo-Rosas L, Albero G, et al. Human Papillomavirus and Related Diseases Report; ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Barcelona, Spain; 2017.
  • Vu LT, Bui D, Le HT. Prevalence of cervical infection with HPV type 16 and 18 in Vietnam: implications for vaccine campaign. BMC Cancer. 2013;13(1):53. doi:10.1186/1471-2407-13-5323374877
  • Chow SN, Soon R, Park JS, et al. Knowledge, attitudes, and communication around human papillomavirus (HPV) vaccination amongst urban Asian mothers and physicians. Vaccine. 2010;28(22):3809–3817. doi:10.1016/j.vaccine.2010.03.02720347631
  • Tran B, Quoc Than PT, Doan T. Knowledge, attitude, and practice on and willingness to pay for human papillomavirus vaccine: a cross-sectional study in Hanoi, Vietnam. Patient Prefer Adherence. 2018;12:945–954. doi:10.2147/PPA.S16535729881260
  • Nguyen TNT, Phan TL, Ngo VT, Nguyen TTD, Vo HP, Nguyen T. Knowledge and practices of HPV vaccination to prevent cervical cancer among women aged 15–49 in Binh Dinh province, 2017. Vietnam J Prevent Med. 2017;27(8):246.
  • Remschmidt C, Walter D, Schmich P, Wetzstein M, Deleré Y, Wichmann O. Knowledge, attitude, and uptake related to human papillomavirus vaccination among young women in Germany recruited via a social media site. Hum Vacc Immunother. 2014;10(9):2527–2535. doi:10.4161/21645515.2014.970920
  • Rondy M, van Lier A, van de Kassteele J, Rust L, de Melker H. Determinants for HPV vaccine uptake in the Netherlands: a multilevel study. Vaccine. 2010;28(9):2070–2075. doi:10.1016/j.vaccine.2009.12.04220045095
  • Thanh Le XT, Ngoc Nguyen PT, Thanh Do TT. Intention to pay for HPV vaccination among women of childbearing age in Vietnam. Environ Res Public Health. 2020;17(9):3144. doi:10.3390/ijerph17093144
  • Agosti JM, Goldie SJ. Introducing HPV vaccine in developing countries – key challenges and issues. N Engl J Med. 2007;356(19):1908–1910. doi:10.1056/NEJMp07805317494923
  • Rajiah K, Maharajan MK, Chin NS, Num KS. Awareness and acceptance of human papillomavirus vaccination among health sciences students in Malaysia. Virus disease. 2015;26(4):297–303. doi:10.1007/s13337-015-0287-326645041
  • Al-Nuaimi NS, Al-Ghas YS, Al-Owais AH, et al. Human papillomavirus vaccination uptake and factors related to uptake in a traditional desert city in the United Arab Emirates. Int J STD AIDS. 2011;22(7):400–404. doi:10.1258/ijsa.2009.00938021729960
  • Ritten CJ, Breunig IM. Willingness to pay for programs for the human papillomavirus vaccine on a rocky mountain west college campus. West Econ Forum. 2013;12(1):15.
  • Locke C, NganHoa NT, Thanh Tam NT. Visiting marriages and remote parenting: changing strategies of rural-urban migrants to Hanoi, Vietnam. J Dev Stud. 2012;48(1):10–25. doi:10.1080/00220388.2011.629650
  • LanAnhThi Do LAT, Boonmongkon P, Paek SC, Guadamuz TE. ‘Hu Hong’ (bad thing): parental perceptions of teenagers’ sexuality in urban Vietnam. BMC Public Health. 2017;17(1):226. doi:10.1186/s12889-017-4133-y28245806
  • Chan SS, Cheung TH, Lo WK, Chung TK. Women’s attitudes on human papillomavirus vaccination to their daughters. J Adolesc Health. 2007;41(2):204–207. doi:10.1016/j.jadohealth.2007.04.01117659226
  • Sherman SM, Nailer E, Minshall C, Coombes R, Cooper J, Redman CW. Awareness and knowledge of HPV and cervical cancer in female students: a survey (with a cautionary note). J Obstet Gynaecol. 2016;36(1):76–80. doi:10.3109/01443615.2015.104188626408400
  • Perez S, Tatar O, Ostini R, et al. Extending and validating a human papilloma virus (HPV) knowledge measure in a national sample of Canadian parents of boys. Preventive medicine. 2016;91:43–49.27471023
  • Waller JO, Ostini R, Marlow LA, McCaffery K, Zimet G. Validation of a measure of knowledge about human papillomavirus (HPV) using item response theory and classical test theory. Prev Med. 2013;56(1):35–40. doi:10.1016/j.ypmed.2012.10.02823142106
  • Fua LY, Bonhommea L-A, Cooperb SC, Joseph JG, Zimetd GD. Educational interventions to increase HPV vaccination acceptance: a systematic review. Vaccine. 2014;32(17):1901–1920. doi:10.1016/j.vaccine.2014.01.09124530401
  • Katz ML, Kam JA, Krieger JL, Roberto AJ. Predicting human papillomavirus vaccine intentions of college- aged males: an examination of parents’ and son’s perceptions. J Am Coll Health. 2012;60(6):449–459. doi:10.1080/07448481.2012.67352322857137
  • Radisic G, Chapman J, Flight I, Wilson C. Factors associated with parents’ attitudes to the HPV vaccination of their adolescent sons: a systematic review. Prev Med. 2017;95:26–37. doi:10.1016/j.ypmed.2016.11.01927932052
  • Krawczyk A, Knäuper B, Gilca V, et al. Parents’ decision-making about the human papillomavirus vaccine for their daughters: I. quantitative results. Hum Vaccin Immunother. 2015;11(2):322–329. doi:10.1080/21645515.2014.100403025692455
  • Zimet GD, Rosenthal SL. HPV vaccine and males: issues and challenges. Gynecol Oncol. 2010;117(2Suppl):S26–31.20129653
  • Schuler CL, DeSousa NS, Coyne-Beasley T. Parents’ decisions about HPV vaccine for sons: the importance of protecting sons’ future female partners. J Community Health. 2014;39(5):842–848. doi:10.1007/s10900-014-9859-124633727
  • Du J, Nordfors C, Ahrlund-Richter A, et al. Prevalence of oral human papillomavirus infections among youth, Sweden. Emerg Infect Dis. 2012;18(9):1468–1471. doi:10.3201/eid1809.11173122932445
  • Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Onco1. 2011;29(32):4294–4301. doi:10.1200/JCO.2011.36.4596
  • Machalek DA, Grulich AE, Jin F, et al. The epidemiology and natural history of anal human papillomavirus infection in men who have sex with men. Sex Health. 2012;9(6):527–537. doi:10.1071/SH1204323380235
  • Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr. 2014;168(1):76–82. doi:10.1001/jamapediatrics.2013.275224276343
  • Farias AJ, Savas LS, Fernandez ME, et al. Association of physicians perceived barriers with human papillomavirus vaccination initiation. Prev Med. 2017;105:219–225. doi:10.1016/j.ypmed.2017.07.01628834689
  • Wong LP. Issues surrounding HPV vaccine delivery in a multi-ethnic country in Asia: the physician’s perspective. J Community Health. 2011;36(1):14–22. doi:10.1007/s10900-010-9275-020431926
  • Loi TT, Nhung BTH. Screening cervical cancer of perimenopausal women in Ho Chi Minh City. HCMH J Med. 2004;8:116–119.
  • Dinh TA, Rosenthal SL, Doan ED. Attitudes of mothers in Da Nang, Vietnam toward a human papillomavirus vaccine. J Adolesc Health. 2007;40(6):559–563. doi:10.1016/j.jadohealth.2007.02.00317531763
  • Nghi NQ, LaMontagne DS, Bingham A, et al. Human papillomavirus vaccine introduction in Vietnam: formative research findings. Sex Health. 2010;7(3):262–270. doi:10.1071/SH0912320719213